EarLens Stock
EarLens is a medical device company specialized in manufacturing hearing aids
Sign up today and learn more about EarLens Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About EarLens Stock
EarLens Corporation is a privately held medical device company committed to providing hearing impaired patients a hearing solution that is designed to change the current standard of care for sound performance. The EarLens System's unique mechanism of direct sound delivery potentially opens the door to a level of sound performance achieved by no hearing aid on the market today. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the EarLens Contact Hearing Device™ is the world’s first to use light to transmit sound.
Funding History
| May 2010 | $4.6M |
|---|---|
| July 2011 | $500K |
| January 2013 | $1.6M |
| April 2014 | $40.0M |
| June 2016 | $34.0M |
| June 2017 | $73.0M |
| June 2017 | $45.0M |
| October 2018 | $87.0M |
Management
CTO
Brent Edwards
Founder and Chief Medical Officer
Dr. Rodney Perkins
CEO
William Facteau
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
